UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause

Fertility and sterility, 2016-12, Vol.106 (7), p.1588-1599

2016

Volltextzugriff (PDF)

Hormone replacement therapy in young women with surgical primary ovarian insufficiency

Fertility and sterility, 2016-12, Vol.106 (7), p.1580-1587

2016

Volltextzugriff (PDF)

Adding up the healthcare costs when estrogen therapy is avoided after hysterectomy

Menopause (New York, N.Y.), 2020-06, Vol.27 (6), p.625-627

Sarrel, Philip M

2020

Volltextzugriff (PDF)

A call to increase the use of hormone therapy to prevent disease in symptomatic postmenopausal women

Menopause (New York, N.Y.), 2019-06, Vol.26 (6), p.573-575

Sarrel, Philip M.

2019

Volltextzugriff (PDF)

Estrogen therapy: economic considerations

Menopause (New York, N.Y.), 2018-05, Vol.25 (5), p.481-482

Sarrel, Philip M.

2018

Volltextzugriff (PDF)

The Mortality Toll of Estrogen Avoidance: An Analysis of Excess Deaths Among Hysterectomized Women Aged 50 to 59 Years

American journal of public health (1971), 2013-09, Vol.103 (9), p.1583-1588

2013

Volltextzugriff (PDF)

Navigating menopause at work: a preliminary study about challenges and support systems

Menopause (New York, N.Y.), 2024-04, Vol.31 (4), p.258-265

2024

Volltextzugriff (PDF)

Women, work, and menopause

Menopause (New York, N.Y.), 2012-03, Vol.19 (3), p.250-252

Sarrel, Philip M

2012

Volltextzugriff (PDF)

A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke

The New England journal of medicine, 2001-10, Vol.345 (17), p.1243-1249

2001

Volltextzugriff (PDF)

Mortality toll due to avoiding estrogen therapy in hysterectomized women: estimates for 2002 – 2011

Climacteric : the journal of the International Menopause Society, 2013-12, Vol.16 (6), p.718-719

Sarrel, Philip M

2013

Volltextzugriff (PDF)

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong

Menopause (New York, N.Y.), 2017-10, Vol.24 (10), p.1101-1112

2017

Volltextzugriff (PDF)

Female androgen insufficiency: the princeton consensus statement on definition, classification, and assessment

Fertility and sterility, 2002-04, Vol.77 (4), p.660-665

2002

Volltextzugriff (PDF)

Katz et al. respond

American journal of public health (1971), 2013-12, Vol.103 (12), p.e3-e3

2013

Volltextzugriff (PDF)

Katz et al. respond

American journal of public health (1971), 2013-12, Vol.103 (12), p.e4-e5

2013

Volltextzugriff (PDF)

Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST)

American journal of obstetrics and gynecology, 2005-02, Vol.192 (2), p.387-393

2005

Volltextzugriff (PDF)

Androgen deficiency: menopause and estrogen-related factors

Fertility and sterility, 2002-04, Vol.77 (4), p.63-67

Sarrel, Philip M

2002

Volltextzugriff (PDF)

The Stroke Prognosis Instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic Stroke

Stroke (1970), 2000-02, Vol.31 (2), p.456-462

2000

Volltextzugriff (PDF)

Sexual dysfunction: treat or refer

Obstetrics and gynecology (New York. 1953), 2005-10, Vol.106 (4), p.834-839

Sarrel, Philip M

2005

Volltextzugriff (PDF)

Employment conditions and work-related stressors are associated with menopausal symptom reporting among perimenopausal and postmenopausal women

Menopause (New York, N.Y.), 2017-03, Vol.24 (3), p.247-251

2017

Volltextzugriff (PDF)

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause (New York, N.Y.), 2017-07, Vol.24 (7), p.728-753

The NAMS 2017 Hormone Therapy Position Statement Advisory Panel

2017

Volltextzugriff (PDF)

Menopause in the workplace: What employers should be doing

Maturitas, 2016-03, Vol.85, p.88-95

2016

Volltextzugriff (PDF)

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy

Annals of internal medicine, 2020-02, Vol.172 (3), p.227

Sarrel, Philip

2020

Volltextzugriff (PDF)

Testosterone therapy for postmenopausal decline in sexual desire: implications of a new study

Menopause (New York, N.Y.), 2006-05, Vol.13 (3), p.328-330

Sarrel, Philip M

2006

Volltextzugriff (PDF)

Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle

Psychopharmacologia, 2005-12, Vol.183 (2), p.181-189

2005

Volltextzugriff (PDF)

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?

Climacteric : the journal of the International Menopause Society, 2018-11, Vol.21 (6), p.521-528

2018

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(150)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause

Hormone replacement therapy in young women with surgical primary ovarian insufficiency

Adding up the healthcare costs when estrogen therapy is avoided after hysterectomy

A call to increase the use of hormone therapy to prevent disease in symptomatic postmenopausal women

Estrogen therapy: economic considerations

The Mortality Toll of Estrogen Avoidance: An Analysis of Excess Deaths Among Hysterectomized Women Aged 50 to 59 Years

Navigating menopause at work: a preliminary study about challenges and support systems

Women, work, and menopause

A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke

Mortality toll due to avoiding estrogen therapy in hysterectomized women: estimates for 2002 – 2011

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong

Female androgen insufficiency: the princeton consensus statement on definition, classification, and assessment

Katz et al. respond

Katz et al. respond

Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST)

Androgen deficiency: menopause and estrogen-related factors

The Stroke Prognosis Instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic Stroke

Sexual dysfunction: treat or refer

Employment conditions and work-related stressors are associated with menopausal symptom reporting among perimenopausal and postmenopausal women

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause in the workplace: What employers should be doing

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy

Testosterone therapy for postmenopausal decline in sexual desire: implications of a new study

Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?

Suchergebnisse filtern